Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2012 Earnings Results

Arrowhead Pharmaceuticals Misses on EPS, Stock Up 2.90%

Arrowhead Pharmaceuticals reported a loss per share of $0.25, but the stock still rose by 2.90%. This increase may reflect investor optimism or market reactions unrelated to the earnings figures, as no revenue data was provided and no guidance was updated.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.25	N/A	—
Revenue	—	N/A	—

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Arrowhead Pharmaceuticals Misses on EPS, Stock Up 2.90%

Key numbers

Management commentary

Arrowhead Pharmaceuticals, Inc.

More earnings this week

Arrowhead Pharmaceuticals Misses on EPS, Stock Up 2.90%

Key numbers

Management commentary